Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Odanacatib, An Investigational Cathepsin K Inhibitor, Reduced Markers Of Bone Turnover In Women With Breast Cancer And Bone Metastases
http://www.medicalnewstoday.com/articles/113959.php
Merck & Co., Inc, Whitehouse Station, NJ, USA, which operates in many countries as Merck Sharp & Dohme or MSD, announced results of a new study in which its investigational selective cathepsin K inhibitor odanacatib reduced measures of bone turnover (breakdown and rebuilding of bone) in women with breast cancer that has spread to the bones (bone metastases).
S.C. Allocates $2M To Expand Breast, Cervical Cancer Screening Program For Low-Income Women
http://www.medicalnewstoday.com/articles/113925.php
<BR />The South Carolina <A href="http://www.scdhec.net/" target=_new>Department of Health and Environmental Control</A> on Tuesday announced the state has allocated $2 million to expand a program that provides no-cost breast and cervical cancer screenings to low-income women, the <A href="http://www.
----------------------------------------------
** CANCER / ONCOLOGY News **
Medicare Adds Third Recognized Source To Help Determine Coverage For Anti-Cancer Chemotherapy Drugs
http://www.medicalnewstoday.com/articles/113978.php
The Centers for Medicare & Medicaid Services (CMS) announced additional updates to the information it uses in determining which drugs may be covered under Medicare Part B when used to treat patients undergoing cancer treatment through chemotherapy.
3rd ESU Masterclass Presents Insightful Updates On Urological Oncology
http://www.medicalnewstoday.com/articles/113967.php
Insightful updates on onco-urological issues were the focus of the 3rd ESU masterclass, which started in Barcelona on Friday 27 June. There were 150 participants who listened to a faculty of 12 internationally renowned experts in urological cancers.
Blood Vessel Inhibitor Shows Promise Against Metastatic Thyroid Cancer
http://www.medicalnewstoday.com/articles/113855.php
Thyroid cancer that has spread to distant sites has a poor prognosis, but an experimental drug that inhibits tumor blood vessel formation can slow disease progression in some patients, a research team led by investigators from The University of Texas M.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
No news for this category today.
----------------------------------------------
** COLORECTAL CANCER News **
No news for this category today.
----------------------------------------------
** LUNG CANCER News **
A Report By Leading Clinical Researchers On The Current Quantitative Imaging Tools For Lung Cancer Drug Assessment
http://www.medicalnewstoday.com/articles/113958.php
<i>Research and Markets</i> has announced the addition of the "Quantitative Imaging Tools for Lung Cancer Drug Assessment" report to their offering. This monograph presents chapters written by leading clinical researchers in the field of lung cancer, where high resolution 3-D imaging technology appears to hold the greatest near-term promise, as well as contributions from recognized experts in CAD, medical information technology systems, regulatory procedure, x-ray standards development, and clinical trial design.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
Funding Boost In Fight Against Leukaemia
http://www.medicalnewstoday.com/articles/113897.php
University of Manchester researchers have been awarded £1.6 million to study a group of genes identified as playing a key role in leukaemia.The grant, by Leukaemia Research, will fund work analysing a wide range of cancer-causing genes in the hope of targeting their common mechanisms of action for patient benefit.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
No news for this category today.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment